{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:51:39Z","timestamp":1768315899470,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:00:00Z","timestamp":1437696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:00:00Z","timestamp":1437696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["HRN-A-00-99-00010"],"award-info":[{"award-number":["HRN-A-00-99-00010"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["GPO-A-00-04-00019-00"],"award-info":[{"award-number":["GPO-A-00-04-00019-00"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["#18057"],"award-info":[{"award-number":["#18057"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Ministry of Foreign Affairs"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10461-015-1123-x","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T08:35:43Z","timestamp":1437640543000},"page":"2565-2577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial"],"prefix":"10.1007","volume":"20","author":[{"given":"Barbara A.","family":"Friedland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Stoner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlena Gehret","family":"Plagianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumen","family":"Govender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neetha","family":"Morar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Altini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Skoler-Karpoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khatija","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Ramjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Monedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka","family":"L\u00e4hteenm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"key":"1123_CR1","unstructured":"UNAIDS. The Gap Report. Geneva: Joint United Nations Programme on HIV\/AIDS, 2014."},{"issue":"7","key":"1123_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0277-9536(94)00165-P","volume":"40","author":"LL Heise","year":"1995","unstructured":"Heise LL, Elias C. Transforming AIDS prevention to meet women\u2019s needs: a focus on developing countries. Soc Sci Med. 1995;40(7):931\u201343.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1123_CR3","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1371\/journal.pone.0001474","volume":"3","author":"P Feldblum","year":"2008","unstructured":"Feldblum P, Adeiga A, Bakare R, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One. 2008;3(1):e1474.","journal-title":"PLoS One"},{"issue":"12","key":"1123_CR4","doi-asserted-by":"publisher","first-page":"e1312","DOI":"10.1371\/journal.pone.0001312","volume":"2","author":"L Peterson","year":"2007","unstructured":"Peterson L, Nanda K, Opoku BK, et al. SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS One. 2007;2(12):e1312.","journal-title":"PLoS One"},{"issue":"9654","key":"1123_CR5","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0140-6736(08)61842-5","volume":"372","author":"S Skoler-Karpoff","year":"2008","unstructured":"Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1932\u20133.","journal-title":"Lancet"},{"key":"1123_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/QAD.0b013e32834541d9","volume":"25","author":"SS Abdool Karim","year":"2011","unstructured":"Abdool Karim SS, Richardson BA, Ramjee G, et al. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011;25:957\u201399.","journal-title":"AIDS."},{"issue":"9749","key":"1123_CR7","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","volume":"376","author":"S McCormack","year":"2010","unstructured":"McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329\u201337.","journal-title":"Lancet"},{"issue":"9338","key":"1123_CR8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","volume":"360","author":"L Van Damme","year":"2002","unstructured":"Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360(9338):971\u20137.","journal-title":"Lancet"},{"issue":"5","key":"1123_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1056\/NEJMoa0707957","volume":"359","author":"L Van Damme","year":"2008","unstructured":"Van Damme L, Govinden R, Mirembe FM, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. NEJM. 2008;359(5):463\u201372. doi:\n                    10.1056\/NEJMoa0707957\n                    \n                  .","journal-title":"NEJM"},{"issue":"5996","key":"1123_CR10","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168\u201374.","journal-title":"Science."},{"issue":"5","key":"1123_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. NEJM. 2012;367(5):411\u201322.","journal-title":"NEJM"},{"issue":"6","key":"1123_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"J Marrazzo","year":"2015","unstructured":"Marrazzo J, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. NEJM. 2015;372(6):509\u201318.","journal-title":"NEJM"},{"issue":"6","key":"1123_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.contraception.2005.06.063","volume":"72","author":"J Trussell","year":"2005","unstructured":"Trussell J, Dominik R. Will microbicide trials yield unbiased estimates of microbicide efficacy? Contraception. 2005;72(6):408\u201313.","journal-title":"Contraception"},{"key":"1123_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-7622-6-5","volume":"6","author":"BR M\u00e2sse","year":"2009","unstructured":"M\u00e2sse BR, Boily MC, Dimitrov D, Desai K. Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. Emerg Themes Epidemiol. 2009;6:5. doi:\n                    10.1186\/1742-7622-6-5\n                    \n                  .","journal-title":"Emerg Themes Epidemiol"},{"issue":"5","key":"1123_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. NEJM. 2012;367(5):399\u2013410.","journal-title":"NEJM"},{"issue":"5","key":"1123_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. NEJM. 2012;367(5):423\u201334.","journal-title":"NEJM"},{"key":"1123_CR17","volume-title":"Drug Delivery and Development of Anti-HIV Microbicides","author":"EE Tolley","year":"2014","unstructured":"Tolley EE, Friedland B, Gafos M, et al. Socioeconomic and behavioral factors influencing choice, adherence and success of microbicide formulations. In: das Neves J, Sarmento B, editors. Drug Delivery and Development of Anti-HIV Microbicides. Singapore: Pan Stanford Publishing; 2014."},{"issue":"3","key":"1123_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/01.qai.0000243056.59860.c1","volume":"43","author":"PH Kilmarx","year":"2006","unstructured":"Kilmarx PH, van de Wijgert JH, Chaikummao S, et al. Safety and acceptability of the candidate microbicide Carraguard in Thai women: findings from a Phase II clinical trial. J Acquir Immune Defic Syndr. 2006;43(3):327\u201334.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"1123_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/OLQ.0b013e31815d6e0d","volume":"35","author":"PH Kilmarx","year":"2008","unstructured":"Kilmarx PH, Blanchard K, Chaikummao S, et al. A randomized, placebo-controlled trial to assess the safety and acceptability of use of Carraguard vaginal gel by heterosexual couples in Thailand. Sex Transm Dis. 2008;35(3):226\u201332.","journal-title":"Sex Transm Dis"},{"issue":"6","key":"1123_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.contraception.2010.04.019","volume":"82","author":"The Carraguard Phase II South Africa Study Team","year":"2010","unstructured":"The Carraguard Phase II South Africa Study Team. Expanded safety and acceptability of the candidate vaginal microbicide Carraguard\u00ae in South Africa. Contraception. 2010;82(6):563\u201371. Epub 2010\/11\/16.","journal-title":"Contraception"},{"issue":"8","key":"1123_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/01.olq.0000135986.35216.ba","volume":"31","author":"A Wallace","year":"2004","unstructured":"Wallace A, Thorn M, Maguire RA, Sudol KM, Phillips DM. Assay for establishing whether microbicide applicators have been exposed to the vagina. Sex Transm Dis. 2004;31(8):465\u20138.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"1123_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.contraception.2006.10.012","volume":"76","author":"AR Wallace","year":"2007","unstructured":"Wallace AR, Teitelbaum A, Wan L, et al. Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials. Contraception. 2007;76(1):53\u20136.","journal-title":"Contraception"},{"issue":"11","key":"1123_CR23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1097\/OLQ.0b013e31822e6160","volume":"38","author":"LL Katzen","year":"2011","unstructured":"Katzen LL, Fern\u00e1ndez-Romero JA, Sarna A, et al. Validation of a dye stain assay for vaginally inserted hydroxyethylcellulose-filled microbicide applicators. Sex Transm Dis. 2011;38(11):1050\u20135.","journal-title":"Sex Transm Dis"},{"issue":"12","key":"1123_CR24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/OLQ.0000000000000040","volume":"40","author":"MJ Keller","year":"2013","unstructured":"Keller MJ, Buckley N, Katzen LL, et al. Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex. Sex Transm Dis. 2013;40(12):939\u201343.","journal-title":"Sex Transm Dis"},{"issue":"2","key":"1123_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1300\/J013v42n02_05","volume":"42","author":"KE Mosack","year":"2005","unstructured":"Mosack KE, Weeks MR, Novick Sylla MR, Abbott M. High-risk women\u2019s willingness to try a simulated vaginal microbicide: results from a pilot study. Women\u2019s Health. 2005;42(2):71\u201388.","journal-title":"Women\u2019s Health"},{"issue":"4","key":"1123_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/OLQ.0b013e3181901aec","volume":"36","author":"AN Turner","year":"2009","unstructured":"Turner AN, Van Damme K, Jamieson DJ, et al. Predictors of adherent use of diaphragms and microbicide gel in a four-arm, randomized pilot study among female sex workers in Madagascar. Sex Transm Dis. 2009;36(4):249\u201357.","journal-title":"Sex Transm Dis"},{"key":"1123_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1745-6215-14-33","volume":"14","author":"A Abaasa","year":"2013","unstructured":"Abaasa A, Crook A, Gafos M, et al. Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda. Trials. 2013;14:33. doi:\n                    10.1186\/1745-6215-14-33\n                    \n                  .","journal-title":"Trials"},{"issue":"6","key":"1123_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.contraception.2008.02.013","volume":"77","author":"A van der Straten","year":"2008","unstructured":"van der Straten A, Moore J, Napierala S, et al. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe. Contraception. 2008;77(6):435\u201343. doi:\n                    10.1016\/j.contraception.2008.02.013\n                    \n                  .","journal-title":"Contraception"},{"issue":"7","key":"1123_CR29","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s10461-011-0036-6","volume":"16","author":"EE Tolley","year":"2012","unstructured":"Tolley EE, Tsui S, Mehendale S, Weaver MA, Kohli R. Predicting product adherence in a topical microbicide safety trial in Pune, India. AIDS Behav. 2012;16(7):1808\u201315. doi:\n                    10.1007\/s10461-011-0036-6\n                    \n                  .","journal-title":"AIDS Behav"},{"issue":"2","key":"1123_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0197-2456(81)90001-5","volume":"2","author":"JM Lachin","year":"1981","unstructured":"Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981;2(2):93\u2013113.","journal-title":"Control Clin Trials"},{"key":"1123_CR31","unstructured":"Li AJ, Karlan BY. Breast cancer prevention. Obstet Gynecol. 2000;Special edition:18\u201322."},{"key":"1123_CR32","unstructured":"Abbott S, Morar N, Madiba S, et al. Microbicides acceptability: the influence of social and cultural norms, interpersonal relations and sexual socialization. In: Presented at the Microbicides 2010 Conference, Pittsburgh, PA, May 22\u201325, 2010 [abstract 032]."},{"key":"1123_CR33","unstructured":"Rees H, Delany-Moretlwe S, Baron D, et al. FACTS 001 phase III trial of pericoital tenofovir 1% gel for HIV prevention in women. In: Presented at the Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Washington, February 23\u201326, 2015 [abstract 26LB]."},{"key":"1123_CR34","first-page":"334","volume":"2","author":"I Rosenstoch","year":"1974","unstructured":"Rosenstoch I. Historical origin of Health Belief model. Health Educ Monogr. 1974;2:334.","journal-title":"Health Educ Monogr"},{"issue":"1","key":"1123_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/109019819001700107","volume":"17","author":"JA Catania","year":"1990","unstructured":"Catania JA, Kegeles SM, Coates TJ. Towards an understanding of risk behavior: an AIDS risk reduction model (ARRM). Health Educ Q. 1990;17(1):53\u201372.","journal-title":"Health Educ Q"},{"key":"1123_CR36","volume-title":"South African National HIV Prevalence, Incidence, Behaviour and Communication Survey 2008: a turning tide among teenagers? Cape Town","author":"O Shisana","year":"2009","unstructured":"Shisana O, Rehle T, Simbayi LC, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey 2008: a turning tide among teenagers? Cape Town, South Africa: HSRC Press; 2009."},{"key":"1123_CR37","unstructured":"Littlefield S, Gehret M, Friedland B, et al. An analysis of varying measures of adherence among women enrolled in the Carraguard\u00ae phase 3 trial. In: Presented at the Microbicides 2008 Conference, New Delhi, India, February 24\u201327, 2008 [abstract 533]."},{"key":"1123_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/9780470594001","volume-title":"Analysis of Ordinal Categorical Data","author":"A Agresti","year":"2010","unstructured":"Agresti A. Analysis of Ordinal Categorical Data. Hoboken: John Wiley and Sons, Inc.; 2010."},{"issue":"4","key":"1123_CR39","first-page":"419","volume":"50","author":"A van der Straten","year":"2009","unstructured":"van der Straten A, Shiboski S, Montgomery ET, et al. Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-Saharan Africa: a trajectory analysis. JAIDS. 2009;50(4):419\u201326.","journal-title":"JAIDS"},{"key":"1123_CR40","first-page":"324","volume":"66","author":"A Corneli","year":"2014","unstructured":"Corneli A, Deese J, Wang M, et al. FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. JAIDS. 2014;66:324\u201331.","journal-title":"JAIDS."},{"issue":"16","key":"1123_CR41","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1097\/QAD.0b013e32834b005d","volume":"25","author":"E Were","year":"2011","unstructured":"Were E, Curran K, Delany-Moretlwe S, et al. A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples. AIDS. 2011;25(16):2009\u201318.","journal-title":"AIDS"},{"issue":"5","key":"1123_CR42","first-page":"555","volume":"67","author":"A Corneli","year":"2014","unstructured":"Corneli A, Wang M, Agot K, et al. Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP. JAIDS. 2014;67(5):555\u201363.","journal-title":"JAIDS"},{"issue":"suppl 4","key":"1123_CR43","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1097\/01.aids.0000390710.04255.2b","volume":"24","author":"R Hayes","year":"2010","unstructured":"Hayes R, Kapiga S, Padian N, McCormack S, Wasserheit J. HIV prevention research: taking stock and the way forward. AIDS. 2010;24(suppl 4):S81\u201392.","journal-title":"AIDS"},{"key":"1123_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/OLQ.0b013e318264f6b0","volume":"39","author":"CK Mauck","year":"2012","unstructured":"Mauck CK, Schwartz JL. Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials. Sex Transm Dis. 2012;39:713\u20135.","journal-title":"Sex Transm Dis"},{"issue":"9665","key":"1123_CR45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(09)60437-2","volume":"373","author":"J van de Wijgert","year":"2009","unstructured":"van de Wijgert J, Jones H, Kilmarx PH. Vaginal microbicide adherence biomarkers should be validated. Lancet. 2009;373(9665):721\u20132.","journal-title":"Lancet"},{"issue":"2","key":"1123_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10461-010-9791-z","volume":"15","author":"BS Mensch","year":"2011","unstructured":"Mensch BS, Hewett PC, Abbott S, et al. Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel. AIDS Behav. 2011;15(2):407\u201321.","journal-title":"AIDS Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-015-1123-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-015-1123-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-015-1123-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-015-1123-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T11:55:36Z","timestamp":1589716536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-015-1123-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1007\/s10461-015-1123-x","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,24]]},"assertion":[{"value":"24 July 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}